Liquid Biopsy Market Size, Key Players Analysis, Competitive Scenario, Opportunities, Development Status 2020-2027

Increasing cancer prevalence globally will boost the growth of the global market for liquid biopsy over the coming years.

The Global Liquid Biopsy Market is forecasted to reach USD 3.55 Billion by 2027, according to a new report by Emergen Research. The rising intake of alcohol and cigarettes has contributed to increased global cancer burden. The incidence of cancer is expected to rise by about 50%, reaching over 15 million new cancer cases by 2020, according to the World Cancer Report. Growing the incidence of disease coupled with minimally invasive cancer diagnostic technology would, therefore, increase market demand. 

Increasing demand for laboratory services would impel segmental growth due to better cost-effectiveness and no need for the skilled labor force. Also, high costs associated with liquid biopsy procedures will fuel demand for liquid biopsy services in the coming years.        

To gain useful market insights, grab a sample copy of this report@ https://www.emergenresearch.com/request-sample/34

Key Highlights From The Report

Based on sample type, other bio fluids generated a revenue of USD 0.17 billion in 2019 and is projected to rise with a CAGR of 11.8% in the forecast period, as saliva and plasma sample provides advantages such as quick assessment of patient health status for accurate cancer diagnosis.

The multi-gene-parallel analysis is expected to grow with a CAGR of 13.8% in the forecasted period, as it helps oncologists to steer patients through the detection of genetic aberrations through targeted therapy, which can be described as a significant step towards systematic cancer genome research.

The therapy selection for metastatic breast cancer application is the major contributor to the Liquid Biopsy Market. The therapy selection for metastatic breast cancer application of the North America region is the major shareholder of the market and held around 41.9% of the market in the year 2019.

North America dominated the market for Liquid Biopsy in 2019. The region's consistent focus on cost-effective and innovative procedures that are adopted in the area is driving the market. The North America region held approximately 51.2% of the market, followed by Europe, which contains around 25.0% market in the year 2019.

Key participants include RainDance Technologies, Personal Genome Diagnostics, Adaptive Biotechnologies, NeoGenomics Laboratories, Guardant Health, Cynvenio, Biocept, Qiagen, Trovagene, and F. Hoffmann-La Roche Ltd., among others.

Liquid Biopsy Market Region:

The report mainly focuses on the key market regions where the market is spread, including North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The report further focuses on the key segments of the market, such as product types, application spectrum, technology, end-user industries, among others.

Inquire To Know Additional List of Market Players Included, Request Here@ https://www.emergenresearch.com/purchase-enquiry/34

The Global Liquid Biopsy Market report is furnished with key market statistics organized in the form of charts, graphs, tables, diagrams, figures, and other pictorial representations. The report offers an exhaustive analysis of the key market aspects like market size, volume, share, current and emerging trends, production and consumption rate, and other key elements that offer an idea about the prospective expansion of the Liquid Biopsy industry.

Sample Type Outlook (Revenue, USD Billion; 2017-2027)
Blood Sample-based
Urine Sample-based
Other Bio Fluids-based
Technology Outlook (Revenue, USD Billion; 2017-2027)
Multi-gene-parallel Analysis (NGS)
Single Gene Analysis (PCR Microarrays)
Application Outlook (Revenue, USD Billion; 2017-2027)
Therapy Selection for Metastatic Breast Cancer
Therapy Selection for Other Metastatic Cancer
Molecular Health Monitoring
Buy Now@ https://www.emergenresearch.com/select-license/34  

The report considers the following timeline for market estimation:

Historical Years: 2017-2018

Base Year: 2019

Estimated Year: 2027

Forecast Years: 2020-2027

Significant Features of the Liquid Biopsy Market Report:

Extensive competitive landscape analysis to offer the readers key insights into driving and restraining factors along with strategies adopted by the key players

Assessment of the existing and emerging trends of the business sphere

Detailed analysis of the emerging growth opportunities and threats and limitations the players might face in the coming years

Significant breakdown of the market to assess the factors that might influence the global market growth

An 8-year forecast for better understanding of the workings and growth opportunities of the market

Read more@ https://www.emergenresearch.com/industry-report/liquid-biopsy-market

Grab Related Report of Liquid Biopsy market By Emergen Research:

Industrial Packaging Market@ https://www.google.com.py/url?q=https://www.emergenresearch.com/industry-report/industrial-packaging-market

Healthcare Cloud Computing Market@ https://www.google.com.pe/url?q=https://www.emergenresearch.com/industry-report/healthcare-cloud-computing-market

Veterinary Vaccines Market@ https://www.google.com.ph/url?q=https://www.emergenresearch.com/industry-report/veterinary-vaccines-market

Industrial Maintenance Coatings Market@ https://www.google.pn/url?q=https://www.emergenresearch.com/industry-report/industrial-maintenance-coatings-market

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs

About Us:

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

This release was published on openPR.